Search results
No PSA Recurrence at 24 Months With Apalutamide Plus ADT After Radical Prostatectomy
MedPage Today· 6 days agoMore than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed...
Could cannabis treat cancer someday? Here's what the science says so far
Live Science via Yahoo News· 3 days agoHowever, so far, there have been only a few small clinical trials, and all have focused on just one...
Cancer: Here's the role exercise plays, from prevention to treatment
Medical Xpress· 1 day agoWith the recent revelations that three members of the royal family have cancer, many people may be...
FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoFibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript May 6, 2024 FibroGen, Inc. misses on...
King Charles III’s openness about cancer has helped him connect with people in year after coronation
KOIN News 6 Portland· 6 days agoLONDON (AP) — King Charles III’s decision to be open about his cancer diagnosis has helped the new...
30-year study will probe cancer disparities in Black women
Axios· 3 days agoWhy it matters: Despite major gains in the past two decades, Black women in the U.S. have the highest death rate and the shortest survival rates of any ...
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
Benzinga via Yahoo Finance· 4 days agoOn Sunday, Johnson & Johnson (NYSE:JNJ) ) released updated results from an open-label, multicenter,...
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
WFRV 5 Green Bay· 1 day agoIn the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden's " ...
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 14 hours agoWith the inclusion of unconfirmed CRs and PRs, the unconfirmed ORR was 24.4%. Among the 32 patients with baseline target lesion measurements in the 2.7...
MacroGenics’ stock crashes after 5 deaths seen in ADC trial
FierceBiotech· 11 hours agoThe phase 2 study assessed two doses of MacroGenics’ B7-H3-directed antibody-drug conjugate (ADC) in...